ASH: Af­ter a pi­lot study of­fers a glimpse of hope for Tes­sa's CD30-tar­get­ing CAR-T, ex­ecs sprint to­ward a piv­otal tri­al

CAR-Ts tar­get­ing CD19 — like Yescar­ta, Kym­ri­ah and the re­cent­ly ap­proved Breyanzi — have shift­ed the par­a­digm for the treat­ment of B cell lym­phoma, ac­cord­ing to Sairah …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER